BANGALORE -- Ranbaxy Laboratories Ltd. Friday said it has launched a generic version of GlaxoSmithKline's anti-herpes medicine Valtrex in the U.S., a development expected to significantly boost its financial results.
Ranbaxy--a unit of Japan's Daiichi Sankyo Co.--launched the generic drug, valacyclovir hydrochloride, in the U.S on Nov. 25.
The details can be read here.
No comments:
Post a Comment